CGFClass I
Radioimmunoassay, Estrone
21 CFR 862.1280 / Clinical Chemistry
CGF is the FDA product code for Radioimmunoassay, Estrone, a class I device type, regulated under 21 CFR 862.1280. As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and 4 recalls.
Classification record
- Product code
- CGF
- Device name
- Radioimmunoassay, Estrone
- Regulation
- 21 CFR 862.1280
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 4
- Ingested recalls
- 4
Clearances, product code CGF
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1984 | 1 |
| 1987 | 1 |
| 1994 | 1 |
| 1997 | 1 |
Applicants with the most clearances
Product code CGF| Applicant | Clearances |
|---|---|
| Diagnostic Systems Laboratories, Inc. | 2 |
| Corning Medical & Scientific | 1 |
| Diagnostics Biochem Canada, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- American Laboratory Products Company
- Diagnostic Automation/ Cortez Diagnostics Inc.
- Diagnostics Biochem Canada, Inc.
- DiaSource ImmunoAssays, SA
- DRG Instruments GmbH
- DRG International, Inc.
- EUROIMMUN Medizinische Labordiagnostika AG
- Euroimmun US Inc.
- Guangzhou Decheng Biotechnology Co., Ltd.
- Immuno-Biological Laboratories, Inc.
- Immunocentrix Corporation
- IMMUNOTECH s.r.o.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
